European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
about
Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing associationManagement of Hidradenitis Suppurativa in Patients with Metabolic ComorbiditiesSpotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativaInterventions for hidradenitis suppurativa: a Cochrane systematic review incorporating GRADE assessment of evidence qualityMedical and Surgical Treatment of Hidradenitis Suppurativa: A Review.Hidradenitis suppurativa: from pathogenesis to diagnosis and treatmentWhat is hidradenitis suppurativa?Qu’est-ce que l’hidradénite suppurée?The Burden of Hidradenitis Suppurativa in a Cohort of Patients in Southern Finland: A Pilot Study.Hidradenitis Suppurativa and Wound Management.Novel Mutations in PSENEN Gene in Two Chinese Acne Inversa Families Manifested as Familial Multiple Comedones and Dowling-Degos DiseaseEvidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.Improvement of overlapping hidradenitis suppurativa and ankylosing spondylitis after the introduction of adalimumab.Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes.Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies.The Hidradenitis suppurativa patient journey in Italy: current status, unmet needs and opportunities.Severe Acne Inversa - Dermatosurgical Approach in a Bulgarian Patient.The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.An Update on Medical Treatment Options for Hidradenitis Suppurativa.Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?Adalimumab for the treatment of hidradenitis suppurativa/acne inversa.Prodromal symptoms in hidradenitis suppurativa.Adalimumab: A Review in Hidradenitis Suppurativa.Population Pharmacokinetics and Immunogenicity of Adalimumab in Adult Patients with Moderate-to-Severe Hidradenitis Suppurativa.Adalimumab for Treating Moderate-to-Severe Hidradenitis Suppurativa: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.A Systematic Review and Critical Evaluation of Reported Pathogenic Sequence Variants in Hidradenitis Suppurativa.Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne.Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up.A Comprehensive Review of Neutrophilic Diseases.High burden of hospital resource utilization in patients with hidradenitis suppurativa in England: a retrospective cohort study using hospital episode statistics.Development and validation of IHS4, a novel dynamic scoring system to assess hidradenitis suppurativa/acne inversa severity.Evidence for a biofilm-based treatment strategy in the management of chronic hidradenitis suppurativa.Hidradenitis suppurativa treated with tetracycline in combination with colchicine: a prospective series of 20 patients.Bacterial biofilm in chronic lesions of hidradenitis suppurativa.Comorbidities, treatment, and outcome in severe anogenital inverse acne (hidradenitis suppurativa): a 15-year single center report.Interventions for hidradenitis suppurativa: an important step towards evidence-based medicine.A consensus-based practical and daily guide for the treatment of acne patients.Beyond the tip of the iceberg: the role of phosphoinositide 3-kinase/AKT in acne inversa/hidradenitis suppurativa.Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum.Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients.
P2860
Q26745455-D581CB77-BC2F-430E-AA33-BDA1D88D13B7Q26747836-74095C45-3CC4-44E6-BEB1-3E342B12276FQ28069719-A8344618-200D-45CA-B3D6-EDBE20A5EFBEQ28074160-DA7D1E22-2C5C-4A86-B303-7B9F7087B770Q30234313-6972411D-A59A-4089-B323-E8EC65E16B9FQ30234599-21C040CE-2500-4A4D-9C92-5848B785B483Q30235909-B40D4A0E-D733-4F1A-9849-BFA0C7165076Q33575025-E0B94421-35C9-4D87-B942-7031155281C7Q33781900-CCDE3423-9078-42D2-BA9C-FC3EF7982C8AQ35739164-76246DB3-7CD2-40A1-A675-5DC1E1A9D7AFQ37487637-9DDCD550-4730-4C47-B0B4-7A646808599BQ37503729-1A0177EB-044E-46F5-8BEB-F3CCBF3ACB6FQ37590677-3DE260A1-99A7-4B94-AB31-7DDB41B09A30Q37681319-D47C34E0-A2A1-438F-8CED-7F0ACB3EAB00Q38543875-6653A28E-B087-403F-8BCD-A59F57045895Q38558963-4D2099C5-2051-4238-923A-8EEECD2C77B5Q38635862-C828C838-1BEB-4B9E-BBA4-225882A6AC0AQ38665824-457F5BB6-3456-4664-B065-FB5426302908Q38667207-E977E5AF-25E8-4FB3-B208-45E575735081Q38863293-763A942C-145D-4713-B232-86B9DE47BD0EQ38929328-126C51DB-90AC-4B48-9C2B-D1B43111B095Q38962830-568E0FCF-1DA7-48D4-83D7-8E57994C8ECBQ38963759-5906F6D8-6778-464B-8216-18187204FD4EQ39032625-ED6859D5-98A4-4BCA-85F4-F5259CC42F61Q39125464-ED83A070-3BB1-4576-960C-762A70B6005CQ39171115-BE505B01-BF39-4C3B-BC7B-072844B11FBCQ39201826-4BD4977E-E38F-433C-BBA3-01BFD904C90FQ39278733-7168BB10-3800-4B4F-94EC-F764B7CB2F5EQ39422179-74632507-2E57-445B-B136-548B0861B597Q39480879-C37D1427-2650-433E-9E26-4D7DFF21BD42Q40163694-D698C4B3-708F-4B5B-8C31-021EFE40A122Q40247598-EB602A34-4C92-4A19-8781-2B2F19AAC1D5Q40384773-5381D087-AABA-4FBD-AC1B-242B0925B65DQ40562171-F39CFDCD-3F6C-49D1-A6DA-35229FA5200EQ40586896-099394D1-46DE-4AEB-8A89-10A18F23E9AFQ40665972-F0146BAD-ABD3-4731-86C7-26CD6D90F0BFQ40675163-3372557C-6B59-4B4C-9295-58A552EB1174Q40745771-45E9D025-AD28-4752-911C-15CC13D7348DQ40881042-19D3CC4D-2FA1-494E-A8B9-95638BBF0849Q40911079-6E606EFA-4C10-4E8B-ABB6-A3E11FB3053B
P2860
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
@ast
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
@en
type
label
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
@ast
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
@en
prefLabel
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
@ast
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
@en
P2093
P2860
P50
P356
P1476
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
@en
P2093
C C Zouboulis
D Ioannides
L Emtestam
R E Hunger
S Schneider-Burrus
P2860
P304
P356
10.1111/JDV.12966
P577
2015-01-30T00:00:00Z